Alliance Pharma plc (APH) — Tangible Net Worth Ratio
Alliance Pharma plc (APH) has a Tangible Net Worth Ratio of -16.0% as of December 2024. This metric is calculated by deducting intangible assets (GBX240.86 Million) from net assets (GBX207.64 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is Alliance Pharma plc's working capital to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Alliance Pharma plc Tangible Net Worth Ratio (1999–2024)
This chart shows how Alliance Pharma plc's Tangible Net Worth Ratio has changed across 27 annual periods from 1999 to 2024. As of December 2024, the ratio stands at -16.0%, reflecting net assets of GBX207.64 Million with intangible assets of GBX240.86 Million GBX. See Alliance Pharma plc (APH) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Alliance Pharma plc (1999–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Alliance Pharma plc from 1999 to 2024, covering 27 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see APH market cap.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -16.0% | GBX207.64 Million | GBX240.86 Million | GBX369.14 Million | ▲ +15.0 pp |
| 2023 | -31.0% | GBX217.87 Million | GBX285.49 Million | GBX414.92 Million | ▲ +8.1 pp |
| 2022 | -39.1% | GBX287.66 Million | GBX400.10 Million | GBX537.41 Million | ▼ -3.7 pp |
| 2021 | -35.4% | GBX282.49 Million | GBX382.51 Million | GBX503.49 Million | ▲ +0.4 pp |
| 2020 | -35.8% | GBX280.96 Million | GBX381.61 Million | GBX508.85 Million | ▼ -22.0 pp |
| 2019 | -13.8% | GBX274.18 Million | GBX312.13 Million | GBX407.64 Million | ▲ +12.5 pp |
| 2018 | -26.4% | GBX252.20 Million | GBX318.68 Million | GBX403.61 Million | ▲ +2.5 pp |
| 2017 | -28.9% | GBX203.38 Million | GBX262.06 Million | GBX336.48 Million | ▲ +9.8 pp |
| 2016 | -38.7% | GBX179.26 Million | GBX248.64 Million | GBX320.74 Million | ▲ +5.3 pp |
| 2015 | -44.0% | GBX162.44 Million | GBX233.91 Million | GBX292.19 Million | ▼ -23.5 pp |
| 2014 | -20.5% | GBX70.78 Million | GBX85.28 Million | GBX107.87 Million | ▲ +11.7 pp |
| 2013 | -32.2% | GBX64.67 Million | GBX85.47 Million | GBX106.99 Million | ▲ +15.0 pp |
| 2012 | -47.2% | GBX51.85 Million | GBX76.30 Million | GBX100.63 Million | ▼ -1.2 pp |
| 2011 | -45.9% | GBX44.13 Million | GBX64.39 Million | GBX82.29 Million | ▲ +16.3 pp |
| 2010 | -62.3% | GBX36.08 Million | GBX58.54 Million | GBX77.40 Million | ▲ +101.1 pp |
| 2009 | -163.3% | GBX16.63 Million | GBX43.79 Million | GBX56.80 Million | ▲ +179.4 pp |
| 2008 | -342.7% | GBX8.77 Million | GBX38.81 Million | GBX48.83 Million | ▲ +127.6 pp |
| 2007 | -470.3% | GBX6.67 Million | GBX38.02 Million | GBX46.41 Million | ▼ -202.8 pp |
| 2006 | -267.5% | GBX10.43 Million | GBX38.33 Million | GBX48.07 Million | ▲ +13.4 pp |
| 2005 | -280.8% | GBX7.50 Million | GBX28.58 Million | GBX35.76 Million | ▲ +30.8 pp |
| 2005 | -311.6% | GBX6.83 Million | GBX28.09 Million | GBX34.30 Million | ▲ +396.8 pp |
| 2004 | -708.4% | GBX2.23 Million | GBX17.99 Million | GBX26.44 Million | ▼ -808.4 pp |
| 2002 | 100.0% | GBX2.24 Million | GBX0.00 | GBX2.26 Million | ▲ +1134.4 pp |
| 2002 | -1034.4% | GBX538.00K | GBX6.10 Million | GBX8.82 Million | ▼ -856.6 pp |
| 2001 | -177.8% | GBX595.00K | GBX1.65 Million | GBX3.99 Million | ▲ +135.0 pp |
| 2000 | -312.9% | GBX451.00K | GBX1.86 Million | GBX4.35 Million | ▲ +1402.9 pp |
| 1999 | -1715.8% | GBX114.00K | GBX2.07 Million | GBX6.57 Million | — |